Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Compare Australian healthcare stocks. See a comparison of key indicators, including healthcare stock price targets and analyst recommendations.
Comparison Results
Performance Comparison
AU:CSL
CSL
271.40
-24.37
-8.24%
AU:RHC
Ramsay Health Care
50.58
-14.35
-22.10%
AU:SHL
Sonic Healthcare Limited
25.91
-8.93
-25.63%
AU:COH
Cochlear Limited
318.89
73.80
30.11%
AU:PME
Pro Medicus Limited
102.09
39.81
63.91%
AU:ANN
Ansell
24.81
-1.83
-6.88%
AU:TLX
Telix Pharmaceuticals Ltd.
13.72
3.93
40.14%
AU:IMU
Imugene Limited
0.08
-0.06
-44.29%
AU:NAN
Nanosonics Limited
2.78
-2.31
-45.38%
AU:ACL
Australian Clinical Labs Ltd
2.40
-1.05
-30.43%
Compare the performance , dividend, and cannabis stocks. Go to the Stock Comparison tool to compare more stocks on key indicators.
Healthcare Stocks Latest News
Currently, no data available
Read the latest stock news and analysis from the TipRanks news team.
Recent Analysts Ratings of Healthcare Stocks
Most Recent Earnings of Healthcare Stocks
CSL
Feb 12, 2024
Dec 01, 2023
5.91
Ramsay Health Care
Feb 28, 2024
Dec 01, 2023
0.829
Sonic Healthcare Limited
Feb 19, 2024
Dec 01, 2023
0.809
Cochlear Limited
Feb 18, 2024
Dec 01, 2023
2.15
Ansell
Feb 19, 2024
Dec 01, 2023
0.793
Telix Pharmaceuticals Ltd.
Feb 22, 2024
Dec 01, 2023
-0.024
Pro Medicus Limited
Feb 14, 2024
Dec 01, 2023
0.26
Imugene Limited
Feb 28, 2024
Dec 01, 2023
-0.003
Nanosonics Limited
Feb 25, 2024
Dec 01, 2023
0.034
Australian Clinical Labs Ltd
Feb 27, 2024
Dec 01, 2023
0.126
Healthcare Stocks - FAQ
Which Healthcare stocks have a "Strong Buy" analyst rating?
These Healthcare stocks currently have a "Strong Buy" analyst rating consensus:
CSL - Strong Buy, based on 10 analyst ratings, 8 Buy, 2 Hold, and 0 Sell.
Telix Pharmaceuticals Ltd. - Strong Buy, based on 5 analyst ratings, 5 Buy, 0 Hold, and 0 Sell.
Australian Clinical Labs Ltd - Strong Buy, based on 4 analyst ratings, 3 Buy, 1 Hold, and 0 Sell.
Are Healthcare stocks overpriced?
CSL's stock price is currently AU$268.92, and its average 12-month price target is AU$313.73.
Ramsay Health Care's stock price is currently AU$50.09, and its average 12-month price target is AU$58.05.
Sonic Healthcare Limited's stock price is currently AU$26.22, and its average 12-month price target is AU$30.76.
Cochlear Limited's stock price is currently AU$315.48, and its average 12-month price target is AU$281.38.
Ansell's stock price is currently AU$24.71, and its average 12-month price target is AU$27.71.
Telix Pharmaceuticals Ltd.'s stock price is currently AU$13.63, and its average 12-month price target is AU$15.63.
Pro Medicus Limited's stock price is currently AU$102.76, and its average 12-month price target is AU$90.12.
Imugene Limited's stock price is currently AU$0.07, and its average 12-month price target is N/A.
Nanosonics Limited's stock price is currently AU$2.73, and its average 12-month price target is AU$3.24.
Australian Clinical Labs Ltd's stock price is currently AU$2.38, and its average 12-month price target is AU$3.23.
Which Healthcare stocks pay dividends?
CSL does not currently pay dividends.
Ramsay Health Care does not currently pay dividends.
Sonic Healthcare Limited does not currently pay dividends.
Cochlear Limited does not currently pay dividends.
Ansell does not currently pay dividends.
Telix Pharmaceuticals Ltd. does not currently pay dividends.
Pro Medicus Limited does not currently pay dividends.
Imugene Limited does not currently pay dividends.
Nanosonics Limited does not currently pay dividends.
Australian Clinical Labs Ltd does not currently pay dividends.
Popular Stocks Comparisons
Latest News
Healthcare Stock Events
Stock | Type | Date |
|---|---|---|
CSL | Earnings Release | Aug 13, 2024 |
Pro Medicus Limited | Earnings Release | Aug 13, 2024 |
Cochlear Limited | Earnings Release | Aug 15, 2024 |
Nanosonics Limited | Earnings Release | Aug 19, 2024 |
Ansell | Earnings Release | Aug 20, 2024 |